| Name | Title | Contact Details |
|---|
Quantum Intech (QI) is a Boulder Creek, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ConsumerMedical is a leading healthcare decision support and concierge company serving approximately 3 million individuals through some of the nation`s largest employers` health plans and private exchanges. As a Medical Ally` ConsumerMedical guides participants throughout their healthcare journey with compassionate` high-touch support and deep clinical expertise. ConsumerMedical offers a fully integrated suite of solutions including Medical Decision Support` Expert Medical Opinions` Claims Advocacy and more` helping individuals and families navigate the healthcare system while reducing unnecessary elective surgeries and driving patients to the highest quality providers. The result is better care for patients` more empowered healthcare decisions for employees and their families` and a better bottom line for business. Headquartered outside Boston in Pembroke` MA` ConsumerMedical employs over100 people.
Nueterra Capital is a private equity investment and advisory firm with an exclusive focus on healthcare. Leveraging a deep understanding of key industry drivers, Nueterra Capital invests in entrepreneurs with innovative minds, while providing professional expertise and back office resources to improve their bottom line performance and drive growth. Nueterra Capital has invested in hundreds of new ventures and continuously delivers the resources and strategic direction that allow our partners to advance and improve every aspect of healthcare.
Lifemark Health Group is a diversified healthcare company in business since 1998 and has grown by acquisition over the past 13 years to include over 200 facilities across Canada.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.